{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:14:31Z","timestamp":1789845271319,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,26]],"date-time":"2017-09-26T00:00:00Z","timestamp":1506384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1055833"],"award-info":[{"award-number":["OPP1055833"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["contraceptionjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.contraception.2017.09.013","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T00:18:01Z","timestamp":1506644281000},"page":"346-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Misreporting of contraceptive hormone use in clinical research participants"],"prefix":"10.1016","volume":"97","author":[{"given":"Sharon L.","family":"Achilles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix G.","family":"Mhlanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petina","family":"Musara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel M.","family":"Poloyac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvavahera M.","family":"Chirenje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.","family":"Hillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2017.09.013_bb0005","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cct.2016.11.006","article-title":"A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: addressing evolving research priorities","volume":"52","author":"Kourtis","year":"2017","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.contraception.2017.09.013_bb0010","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/QAD.0b013e32835ad473","article-title":"Hormonal contraceptive use and risk of HIV-1 disease progression","volume":"27","author":"Heffron","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2017.09.013_bb0015","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1097\/QAD.0000000000000827","article-title":"Effectiveness of hormonal contraception in HIV-infected women using antiretroviral therapy","volume":"29","author":"Pyra","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2017.09.013_bb0020","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S1473-3099(15)00429-6","article-title":"Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study","volume":"16","author":"Byrne","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.contraception.2017.09.013_bb0025","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/QAI.0000000000000531","article-title":"Effect of hormonal contraception on the function of plasmacytoid dendritic cells and distribution of immune cell populations in the female reproductive tract","volume":"68","author":"Michel","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2017.09.013_bb0030","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/aji.12415","article-title":"Injectable progestin-only contraception is associated with increased levels of pro-inflammatory cytokines in the female genital tract","volume":"74","author":"Deese","year":"2015","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.contraception.2017.09.013_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAI.0000000000000533","article-title":"Depot medroxyprogesterone acetate use is associated with elevated innate immune effector molecules in cervicovaginal secretions of HIV-1-uninfected women","volume":"69","author":"Guthrie","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.contraception.2017.09.013_bb0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jri.2015.03.007","article-title":"Lower concentrations of chemotactic cytokines and soluble innate factors in the lower female genital tract associated with the use of injectable hormonal contraceptive","volume":"110","author":"Ngcapu","year":"2015","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.contraception.2017.09.013_bb0045","doi-asserted-by":"crossref","first-page":"e00221","DOI":"10.1128\/mBio.00221-15","article-title":"The contribution of cervicovaginal infections to the immunomodulatory effects of hormonal contraception","volume":"6","author":"Fichorova","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.contraception.2017.09.013_bb0050","first-page":"590","article-title":"Genital injury signatures and microbiome alterations associated with depot medroxyprogesterone acetate usage and intravaginal drying practices","volume":"215","author":"Birse","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.contraception.2017.09.013_bb0055","doi-asserted-by":"crossref","first-page":"e0143109","DOI":"10.1371\/journal.pone.0143109","article-title":"Immune activation in the female genital tract: expression profiles of soluble proteins in women at high risk for HIV infection","volume":"11","author":"Francis","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.contraception.2017.09.013_bb0060","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s10461-014-0741-z","article-title":"Are hormonal contraceptive users more likely to misreport unprotected sex? Evidence from a biomarker validation study in Zimbabwe","volume":"18","author":"McCoy","year":"2014","journal-title":"AIDS Behav"},{"key":"10.1016\/j.contraception.2017.09.013_bb0065","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s10461-016-1563-y","article-title":"Objective measurement of inaccurate condom use reporting among women using depot medroxyprogesterone acetate for contraception","volume":"21","author":"Heffron","year":"2016","journal-title":"AIDS Behav"},{"key":"10.1016\/j.contraception.2017.09.013_bb0070","doi-asserted-by":"crossref","first-page":"393e1","DOI":"10.1016\/j.ajog.2016.12.005","article-title":"Validity of self-reported history of Chlamydia trachomatis infection","volume":"216","author":"Frisse","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2017.09.013_bb0075","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/02791072.2015.1073412","article-title":"Biochemical validation of self-reported smokeless tobacco abstinence among smokeless tobacco users: results from a clinical trial of varenicline in India","volume":"47","author":"Jain","year":"2015","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.contraception.2017.09.013_bb0080","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2015.03.016","article-title":"Pharmacy claims data versus patient self-report to measure contraceptive method continuation","volume":"92","author":"Triebwasser","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.09.013_bb0085","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.contraception.2014.11.011","article-title":"Self-reported and verified compliance in a phase 3 clinical trial of a novel low-dose contraceptive patch and pill","volume":"91","author":"Kaunitz","year":"2015","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.09.013_bb0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.annepidem.2014.10.009","article-title":"A comparison of self-reported oral contraceptive use and automated pharmacy data in perimenopausal and early postmenopausal women","volume":"25","author":"Spangler","year":"2015","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.contraception.2017.09.013_bb0095","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1097\/QAD.0000000000001228","article-title":"An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women","volume":"30","author":"Polis","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.contraception.2017.09.013_bb0100","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.contraception.2011.09.019","article-title":"Predictors of noncompliance in an oral contraceptive clinical trial","volume":"85","author":"Westhoff","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.09.013_bb0105","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1373\/clinchem.2003.025478","article-title":"Liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of estradiol and estrone in human plasma","volume":"50","author":"Nelson","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.contraception.2017.09.013_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jchromb.2005.01.012","volume":"825","author":"Li","year":"2005","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.contraception.2017.09.013_bb0115","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/0002-9378(90)90551-H","article-title":"Pharmacokinetics of the contraceptive steroids levonorgestrel and gestodene after single and multiple oral administration to women","volume":"163","author":"Kuhnz","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2017.09.013_bb0120","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.contraception.2014.06.033","article-title":"Correcting oral contraceptive pharmacokinetic alterations due to obesity: a randomized controlled trial","volume":"90","author":"Edelman","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.09.013_bb0125","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.contraception.2010.01.016","article-title":"Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women","volume":"81","author":"Westhoff","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2017.09.013_bb0130","first-page":"100","article-title":"Pharmacokinetics of oral combination contraceptive drugs containing ethinyl estradiol and levonorgestrel in healthy female Chinese volunteers","volume":"66","author":"Xin","year":"2016","journal-title":"Drug Res (Stuttg)"},{"key":"10.1016\/j.contraception.2017.09.013_bb0135","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6904-12-8","article-title":"Effect of exenatide on the pharmacokinetics of a combination oral contraceptive in healthy women: an open-label, randomised, crossover trial","volume":"12","author":"Kothare","year":"2012","journal-title":"BMC Clin Pharmacol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782417304705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782417304705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T05:51:31Z","timestamp":1575352291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782417304705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S0010782417304705"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2017.09.013","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Misreporting of contraceptive hormone use in clinical research participants","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2017.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}